Related Experiment Video
Updated: Dec 28, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
The nocebo effect and tobacco control-First, do no harm?
Emiel A De Jaeghere1, Gauthier Bouche2, Piet Hoebeke3
1Medical Oncology, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Fear appeals in tobacco prevention may backfire, causing unintended negative health effects. Further research is needed to understand and mitigate these nocebo effects for effective public health strategies.
Area of Science:
- Public Health
- Psychology
- Preventive Medicine
Background:
- Tobacco use is a major global health burden, necessitating effective prevention strategies.
- Fear appeals are commonly used in public health campaigns to deter tobacco consumption.
- The potential for negative unintended consequences of fear appeals is not fully understood.
Purpose of the Study:
- To highlight the risk of fear appeals in tobacco prevention eliciting nocebo effects.
- To emphasize the need for understanding nocebo effects in preventive medicine.
- To advocate for research into mitigating strategies for negative health impacts.
Main Methods:
- Review of existing literature on fear appeals and nocebo effects.
- Argumentative analysis of the psychological mechanisms involved.
- Identification of research gaps in preventive medicine.
Main Results:
- Fear appeals, despite good intentions, can lead to adverse psychological and physiological responses (nocebo effects).
- There is a lack of empirical data on the prevalence and impact of nocebo effects from tobacco control messaging.
- Current preventive strategies may not adequately account for these potential negative outcomes.
Conclusions:
- Public health initiatives using fear appeals must consider the potential for nocebo effects.
- Further investigation into nocebo effects is crucial for developing safer and more effective tobacco prevention campaigns.
- Strategies to mitigate negative health consequences associated with fear appeals require development and validation.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
The Placebo Effect
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Blind Procedures
Classical Conditioning in Daily Life
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...